News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BaroFold, Inc. Grants Protein Technology Research License To Pfizer Inc. (PFE)



1/9/2007 11:55:41 AM

BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc. announced today the granting of a multi-site research license to Pfizer, Inc. (NYSE: PFE) for BaroFold’s proprietary PreEMT™ high pressure technology for solubilizing, disaggregating and refolding proteins. Financial terms were not disclosed. Pfizer joins several other biotechnology firms and pharmaceutical corporations who have licensed BaroFold’s technology to refold and produce proteins.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES